ATE202481T1 - Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege - Google Patents

Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege

Info

Publication number
ATE202481T1
ATE202481T1 AT97954029T AT97954029T ATE202481T1 AT E202481 T1 ATE202481 T1 AT E202481T1 AT 97954029 T AT97954029 T AT 97954029T AT 97954029 T AT97954029 T AT 97954029T AT E202481 T1 ATE202481 T1 AT E202481T1
Authority
AT
Austria
Prior art keywords
colistine
biologically active
preparation
treatment
components
Prior art date
Application number
AT97954029T
Other languages
German (de)
English (en)
Inventor
Donald R Vandevanter
Alan B Montgomery
Original Assignee
Pathogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/799,200 external-priority patent/US5821623A/en
Application filed by Pathogenesis Corp filed Critical Pathogenesis Corp
Application granted granted Critical
Publication of ATE202481T1 publication Critical patent/ATE202481T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
AT97954029T 1996-11-15 1997-11-13 Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege ATE202481T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3093996P 1996-11-15 1996-11-15
US08/799,200 US5821623A (en) 1996-02-26 1997-02-13 Multi-layer gate structure
PCT/US1997/021829 WO1998020836A2 (en) 1996-11-15 1997-11-13 Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections

Publications (1)

Publication Number Publication Date
ATE202481T1 true ATE202481T1 (de) 2001-07-15

Family

ID=26706611

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97954029T ATE202481T1 (de) 1996-11-15 1997-11-13 Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege

Country Status (7)

Country Link
EP (1) EP0920324B1 (enExample)
JP (2) JP2001505557A (enExample)
AT (1) ATE202481T1 (enExample)
AU (1) AU730546B2 (enExample)
CA (1) CA2242335A1 (enExample)
DE (1) DE69705414T2 (enExample)
WO (1) WO1998020836A2 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2316273A1 (en) 1998-01-16 1999-07-22 Takeda Chemical Industries, Ltd. Sustained-release composition, method of its production and use thereof
GB9820746D0 (en) * 1998-09-23 1998-11-18 Pharmax Limited Micronised pharmaceutical compositions
JP4777574B2 (ja) * 2000-02-11 2011-09-21 レスピロニクス・レスピラトリー・ドラッグ・デリバリー・（ユーケー）・リミテッド 薬剤投与装置
US8820316B2 (en) 2000-02-11 2014-09-02 Respironics Respiratory Drug Delivery (Uk) Ltd Drug delivery apparatus
EP1129705A1 (en) * 2000-02-17 2001-09-05 Rijksuniversiteit te Groningen Powder formulation for inhalation
EP1488819A1 (en) 2003-06-16 2004-12-22 Rijksuniversiteit te Groningen Dry powder inhaler and method for pulmonary inhalation of dry powder
CN101296938B (zh) * 2006-08-15 2012-04-11 明治制果株式会社 粘菌素原料粉末的制造方法
IN2012DN02454A (enExample) * 2009-10-30 2015-08-21 Xellia Pharmaceuticals Aps
CN102190712A (zh) * 2010-01-22 2011-09-21 上海医药工业研究院 多黏菌素e1组合物及其制备方法和用途
JP6316846B2 (ja) 2013-01-11 2018-04-25 クセリア ファーマシューティカルズ エーピーエスＸｅｌｌｉａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ ＡｐＳ ポリミキシン含有組成物
CA2937311A1 (en) 2014-01-24 2015-07-30 Ea Pharma Co., Ltd. Megalin antagonist
FR3016888B1 (fr) 2014-01-27 2021-01-22 Centre Nat Rech Scient Synthetases de la colistine et cluster de genes correspondants
EP3166960B1 (en) 2014-07-09 2019-08-07 Xellia Pharmaceuticals ApS Low substituted polymyxins and compositions thereof
GB201416788D0 (en) * 2014-09-23 2014-11-05 Univ Glasgow Therapeutic applications for pyocins
HUE052028T2 (hu) * 2014-10-03 2021-04-28 Xellia Pharmaceuticals Aps Kompozíciók
ES2721401T3 (es) 2014-10-03 2019-07-31 Xellia Pharmaceuticals Aps Dispositivo de inhalación
EP3366284A1 (en) 2017-02-27 2018-08-29 Zambon S.p.A. Association of n-acetylcysteine and colistin for use in bacterial infections
US20240058375A1 (en) * 2021-01-01 2024-02-22 Purdue Research Foundation Co-formulation of polymyxins for inhalation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2124060B1 (enExample) * 1971-02-02 1974-04-12 Rhone Poulenc Sa

Also Published As

Publication number Publication date
CA2242335A1 (en) 1998-05-22
JP2007302698A (ja) 2007-11-22
DE69705414T2 (de) 2002-05-02
JP2001505557A (ja) 2001-04-24
EP0920324A2 (en) 1999-06-09
DE69705414D1 (de) 2001-08-02
EP0920324A4 (enExample) 1999-06-09
WO1998020836A3 (en) 1998-07-09
WO1998020836A2 (en) 1998-05-22
AU5790998A (en) 1998-06-03
AU730546B2 (en) 2001-03-08
EP0920324B1 (en) 2001-06-27

Similar Documents

Publication Publication Date Title
ATE202481T1 (de) Reines, biologisch aktives colistin, seine bestandteile und eine colistin-zubereitung zur behandlung von entzündungen der atemwege
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
TW329387B (en) Pharmaceutical composition for treating airway passage and lung diseases comprising mometasone furoate
HUP9701059A2 (hu) Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására
EP0391002A3 (en) Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid
HU913497D0 (en) Process for the production of 3-(2h)-piridazinone-derivatives, and medical preparations containing such active agents
BG102689A (bg) Фармацевтичен аерозолен състав за използване при лечение на респираторни смущения
DK0656206T3 (da) Aerosolformuleringer uden chlorfluorcarbonforbindelser
ES8602763A1 (es) Un procedimiento para la preparacion de n-(heterociclilbiciclo)-4-piperidinaminas.
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
CA2115442A1 (en) Pharmaceutical preparation containing an uricosuric agent and an excitatory amino acid antagonist
ATE336997T1 (de) Fulvinsäure und dessen verwendung zur behandlung von diversen krankheitszuständen
UA35567C2 (uk) Фармацевтичний препарат для лікування хворих з порушеннями функції коагуляції, спосіб лікування таких хворих, спосіб одержання фармацевтичного препарату
ATE219942T1 (de) Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält
IL97892A0 (en) 2,9-disubstituted-4h-pyrido(1,2-a)pyrimidin-4-ones,their preparation and pharmaceutical compositions containing them
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
PT1223972E (pt) Suspensao de uma proteina de epi-hne processo para a sua preparacao aerossol de po anidro derivado dela composicoes farmaceuticas contendo a referida suspensao ou aerossol e as suas utilizacoes
YU242789A (en) New compound, 4-fluoro-2-//(4-metoxy-2-pyridin-yl)methylsulphinyl/-1h-benzimidazole and process for obtaining
DE60018545D1 (de) Zusammensetzung zur Behandlung von degenerativen Gelenkerkrankungen
FI932654A0 (fi) Hydroxamsyraderivat, som hindrar lipoxigenas
ATE347357T1 (de) Zusammensetzungen, welche tetracycline enthalten, zur behandlung oder verhinderung von mukositis
DE69119488D1 (de) Disulfat von WS-7622A, Verfahren zur Herstellung und Benutzung
HUT62474A (en) Process for producing veterinary composition with antiparasitic effect
UA41326C2 (uk) Фармацевтична композиція для профілактики або лікування вірусних захворювань, засіб для профілактики або лікування вірусних захворювань
SE8400971D0 (sv) Profylaktiskt och lekande medel for arterioskleros